WAFERIX Trademark

Trademark Overview

On Tuesday, January 5, 2021, a trademark application was filed for WAFERIX with the United States Patent and Trademark Office. The USPTO has given the WAFERIX trademark a serial number of 79303987. The federal status of this trademark filing is REGISTERED as of Tuesday, June 7, 2022. This trademark is owned by IX BIOPHARMA LTD.. The WAFERIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, drug delivery agents in the form of dissolvable wafers that facilitate the delivery of pharmaceuticals
waferix

General Information

Serial Number79303987
Word MarkWAFERIX
Filing DateTuesday, January 5, 2021
Status700 - REGISTERED
Status DateTuesday, June 7, 2022
Registration Number6749102
Registration DateTuesday, June 7, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 15, 2022

Trademark Statements

Description of MarkThe mark consists of the stylized wording "WAFERIX" centered in a circle comprised of shaded squares.
Goods and ServicesPharmaceutical preparations, namely, drug delivery agents in the form of dissolvable wafers that facilitate the delivery of pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, February 13, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIX BIOPHARMA LTD.
Party Type30 - Original Registrant
Legal Entity Type84 - NOT AVAILABLE
AddressSG
Party NameIX BIOPHARMA LTD.
Party Type20 - Owner at Publication
Legal Entity Type84 - NOT AVAILABLE
AddressSG
Party NameIX BIOPHARMA LTD.
Party Type10 - Original Applicant
Legal Entity Type84 - NOT AVAILABLE
AddressSG

Trademark Events

Event DateEvent Description
Friday, September 29, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, October 10, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, September 19, 2022FINAL DISPOSITION NOTICE SENT TO IB
Monday, September 19, 2022FINAL DISPOSITION PROCESSED
Wednesday, September 7, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, August 26, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 26, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 26, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 26, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 7, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 7, 2022REGISTERED-PRINCIPAL REGISTER
Friday, April 29, 2022ELECTRONIC RECORD REVIEW COMPLETE
Friday, April 1, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Saturday, March 12, 2022CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, February 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 15, 2022PUBLISHED FOR OPPOSITION
Monday, February 14, 2022NOTIFICATION PROCESSED BY IB
Wednesday, January 26, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 26, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 12, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 12, 2022ASSIGNED TO LIE
Wednesday, January 12, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 6, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 5, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 5, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, November 8, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, November 8, 2021FINAL REFUSAL E-MAILED
Monday, November 8, 2021FINAL REFUSAL WRITTEN
Saturday, October 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 8, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 8, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, August 15, 2021REFUSAL PROCESSED BY IB
Tuesday, July 27, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, July 27, 2021REFUSAL PROCESSED BY MPU
Wednesday, July 21, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, July 20, 2021NON-FINAL ACTION WRITTEN
Wednesday, July 14, 2021ASSIGNED TO EXAMINER
Wednesday, February 17, 2021APPLICATION FILING RECEIPT MAILED
Saturday, February 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 11, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

waferix delivery dissolvable wafers facilitate pharmaceuticals form agents preparations namely drug